US Patent 7700822 Modulation of cytochrome P450 reductase activity
Patent 7700822 was granted and assigned to Cancer Research Technology Limited on April, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 27, 2002
Date of Patent
April 20, 2010
Patent Application Number
10306559
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7700822 Modulation of cytochrome P450 reductase activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.